Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 0.562 EUR -2.09% Market Closed
Market Cap: 74.3m EUR

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

Lowest
Price Target
1.414 EUR
152% Upside
Average
Price Target
1.734 EUR
209% Upside
Highest
Price Target
2.1 EUR
274% Upside
Transgene SA Competitors:
Price Targets
SLNO
Soleno Therapeutics Inc
46% Upside
VCYT
Veracyte Inc
63% Upside
ORY
Oryzon Genomics SA
175% Upside
LYTIX
Lytix Biopharma AS
79% Upside
ELDN
Eledon Pharmaceuticals Inc
251% Upside
RAPT
Rapt Therapeutics Inc
494% Upside
2616
CStone Pharmaceuticals
20% Downside
4893
Noile-Immune Biotech Inc
181% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 19%.

-3%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
1.734 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 19%.

Back to Top